Record Information |
---|
Version | 1.0 |
---|
Creation Date | 2016-05-22 05:20:00 UTC |
---|
Update Date | 2016-11-09 01:15:49 UTC |
---|
Accession Number | CHEM018554 |
---|
Identification |
---|
Common Name | Neboglamine |
---|
Class | Small Molecule |
---|
Description | Neboglamine (INN) (developmental code names CR-2249, XY-2401), formerly known as nebostinel, is a positive allosteric modulator of the glycine site of the NMDA receptor which is under investigation for Rottapharm for the treatment of schizophrenia and cocaine dependence. It shows cognition- and memory-enhancing effects in animal models. As of June 2015, it is in phase II clinical trials for both schizophrenia and cocaine abuse. |
---|
Contaminant Sources | - ToxCast & Tox21 Chemicals
|
---|
Contaminant Type | Not Available |
---|
Chemical Structure | |
---|
Synonyms | Value | Source |
---|
(S)-4-Amino-5-((4,4-dimethylcyclohexyl)amino)-5-oxopentanoic acid | MeSH | (S)-4-Amino-N-(4,4-dimethylcyclohexyl)glutaramic acid | MeSH | 4-Amino-5-((4,4-dimethylcyclohexyl)amino)-5-oxopentanoic acid | MeSH | XY-2401CR-2249neboglamine | ChEMBL | (4S)-4-amino-5-[(4,4-Dimethylcyclohexyl)amino]-5-oxopentanoate | Generator | Neboglamine | MeSH | (4S)-4-Amino-4-[(4,4-dimethylcyclohexyl)-C-hydroxycarbonimidoyl]butanoate | Generator |
|
---|
Chemical Formula | C13H24N2O3 |
---|
Average Molecular Mass | 256.346 g/mol |
---|
Monoisotopic Mass | 256.179 g/mol |
---|
CAS Registry Number | 163000-63-3 |
---|
IUPAC Name | (4S)-4-amino-4-[(4,4-dimethylcyclohexyl)-C-hydroxycarbonimidoyl]butanoic acid |
---|
Traditional Name | (4S)-4-amino-4-[(4,4-dimethylcyclohexyl)-C-hydroxycarbonimidoyl]butanoic acid |
---|
SMILES | [H][C@](N)(CCC(O)=O)C(O)=NC1CCC(C)(C)CC1 |
---|
InChI Identifier | InChI=1S/C13H24N2O3/c1-13(2)7-5-9(6-8-13)15-12(18)10(14)3-4-11(16)17/h9-10H,3-8,14H2,1-2H3,(H,15,18)(H,16,17)/t10-/m0/s1 |
---|
InChI Key | VCRGLZYPNNAVRP-JTQLQIEISA-N |
---|
Chemical Taxonomy |
---|
Description | belongs to the class of organic compounds known as glutamic acid and derivatives. Glutamic acid and derivatives are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Glutamic acid and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Glutamic acid or derivatives
- Alpha-amino acid amide
- Amino fatty acid
- Fatty amide
- N-acyl-amine
- Fatty acyl
- Fatty acid
- Carboxamide group
- Amino acid
- Secondary carboxylic acid amide
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Organonitrogen compound
- Hydrocarbon derivative
- Organic nitrogen compound
- Primary aliphatic amine
- Organic oxide
- Organopnictogen compound
- Carbonyl group
- Organic oxygen compound
- Amine
- Organooxygen compound
- Primary amine
- Aliphatic homomonocyclic compound
|
---|
Molecular Framework | Aliphatic homomonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Biological Properties |
---|
Status | Detected and Not Quantified |
---|
Origin | Not Available |
---|
Cellular Locations | Not Available |
---|
Biofluid Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | Not Available |
---|
Applications | Not Available |
---|
Biological Roles | Not Available |
---|
Chemical Roles | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Appearance | Not Available |
---|
Experimental Properties | Property | Value |
---|
Melting Point | Not Available | Boiling Point | Not Available | Solubility | Not Available |
|
---|
Predicted Properties | |
---|
Spectra |
---|
Spectra | Spectrum Type | Description | Splash Key | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-0570-1890000000-df97b724125eff77162a | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-004i-4910000000-c1cef0ef891e5ebff8ba | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0a4i-9200000000-6ed5871b101729138a34 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-0a4i-0290000000-aca594db0e26e1fc9a6b | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-056r-0950000000-55a63b44a8b2182fb2e7 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-05di-4900000000-baad5b6e05c2a234550f | Spectrum |
|
---|
Toxicity Profile |
---|
Route of Exposure | Not Available |
---|
Mechanism of Toxicity | Not Available |
---|
Metabolism | Not Available |
---|
Toxicity Values | Not Available |
---|
Lethal Dose | Not Available |
---|
Carcinogenicity (IARC Classification) | Not Available |
---|
Uses/Sources | Not Available |
---|
Minimum Risk Level | Not Available |
---|
Health Effects | Not Available |
---|
Symptoms | Not Available |
---|
Treatment | Not Available |
---|
Concentrations |
---|
| Not Available |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
HMDB ID | Not Available |
---|
FooDB ID | Not Available |
---|
Phenol Explorer ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
BiGG ID | Not Available |
---|
BioCyc ID | Not Available |
---|
METLIN ID | Not Available |
---|
PDB ID | Not Available |
---|
Wikipedia Link | Neboglamine |
---|
Chemspider ID | Not Available |
---|
ChEBI ID | Not Available |
---|
PubChem Compound ID | 3074827 |
---|
Kegg Compound ID | Not Available |
---|
YMDB ID | Not Available |
---|
ECMDB ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
MSDS | Not Available |
---|
General References | Not Available |
---|